METASTATIC COLORECTAL CARCINOMA
Clinical trials for METASTATIC COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a pill help the liver regrow and make more cancer surgeries possible?
Disease control Not yet recruitingThis trial tests a drug called HRX215 in 80 adults with colorectal cancer that has spread to the liver. Before surgery to remove liver tumors, patients often get a procedure (PVE) that blocks blood flow to the tumor area to encourage the healthy part of the liver to grow. HRX215 …
Matched conditions: METASTATIC COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a smaller dose of this cancer drug still work? new trial aims to find out
Disease control Not yet recruitingThis phase 2 trial is testing whether a lower dose of the immunotherapy drug nivolumab, given less often, can still control cancer in people with various advanced or metastatic cancers. The goal is to see if a cheaper, more accessible regimen works as well as the standard high-co…
Matched conditions: METASTATIC COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Blood filter aims to suck cancer cells out of patients with advanced tumors
Disease control Not yet recruitingThis study tests a device called ONCObind that filters cancer cells from the blood of people with advanced pancreatic or colorectal cancer that has not responded to standard treatments. About 120 adults will receive the filtering procedure multiple times to see if it is safe and …
Matched conditions: METASTATIC COLORECTAL CARCINOMA
Phase: NA • Sponsor: ExThera Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Misted chemotherapy shows promise for Hard-to-Treat abdominal cancers
Disease control Not yet recruitingThis phase 3 trial tests a new method called PIPAC that delivers chemotherapy as a pressurized mist directly into the abdomen during a minimally invasive procedure. It compares this approach plus standard intravenous chemo (FOLFIRI) to standard chemo alone for people with appendi…
Matched conditions: METASTATIC COLORECTAL CARCINOMA
Phase: PHASE3 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC